Journal article · 2022 · Open access

Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations

Que-Huong Tran, Quoc‐Thai Nguyen, Nguyen-Quynh-Huong Vo, Tan Thanh Mai, Thi-Thuy-Nga Tran, Thanh‐Dao Tran, Minh-Tri Le, Dieu-Thuong Thi Trinh, Khac‐Minh Thai

PLoS ONE, 17(4), e0266632 · Published 6 April 2022 · DOI 10.1371/journal.pone.0266632

Open PDFView at the publisherCite this paper

In brief

“Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations” is a 2022 journal article by Que-Huong Tran and 8 co-authors, published in PLoS ONE. OpenAlex counts 56 citations as of 21 November 2026, which puts it in the top 3% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at PLoS ONE.

Citations
56
Most cited in
2025 (17)
Field-weighted impact
3.73
References
42
Authors
9

Abstract

Interleukin 6 (IL-6) is a cytokine with various biological functions in immune regulation, hematopoiesis, and inflammation. Elevated IL-6 levels have been identified in several severe disorders such as sepsis, acute respiratory distress syndrome (ARDS), and most recently, COVID-19. The biological activity of IL-6 relies on interactions with its specific receptor, IL-6Rα, including the membrane-bound IL-6 receptor (mIL-6R) and the soluble IL-6 receptor (sIL-6R). Thus, inhibition of the interaction between these two proteins would be a potential treatment for IL-6 related diseases. To date, no orally available small-molecule drug has been approved. This study focuses on finding potential small molecules that can inhibit protein-protein interactions between IL-6 and its receptor IL-6Rα using its crystal structure (PDB ID: 5FUC). First, two pharmacophore models were constructed based on the interactions between key residues of IL-6 (Phe74, Phe78, Leu178, Arg179, Arg182) and IL-6Rα (Phe229, Tyr230, Glu277, Glu278, Phe279). A database of approximately 22 million compounds was screened using 3D-pharmacophore models, molecular docking models, and ADMET properties. By analyzing the interactive capability of successfully docked compounds with important amino acids, 12 potential ligands were selected for further analysis via molecular dynamics simulations. Based on the stability of the complexes, the high interactions rate of each ligand with the key residues of IL-6/IL-6Rα, and the low binding free energy calculation, two compounds ZINC83804241 and ZINC02997430, were identified as the most potential IL-6 inhibitor candidates. These results will pave the way for the design and optimization of more specific compounds to combat cytokine storm in severe coronavirus patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tran, Q.-H., Nguyen, Q., Vo, N.-Q.-H., Mai, T. T., Tran, T.-T.-N., Tran, T., Le, M.-T., Trinh, D.-T. T., & Thai, K. (2022). Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations. PLoS ONE, 17(4), e0266632. https://doi.org/10.1371/journal.pone.0266632

MLA 9

Tran, Que-Huong, et al. “Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations.” PLoS ONE, vol. 17, no. 4, 2022, p. e0266632. https://doi.org/10.1371/journal.pone.0266632.

Chicago

Tran, Que-Huong, Quoc‐Thai Nguyen, Nguyen-Quynh-Huong Vo, Tan Thanh Mai, Thi-Thuy-Nga Tran, Thanh‐Dao Tran, Minh-Tri Le, Dieu-Thuong Thi Trinh, and Khac‐Minh Thai. 2022. “Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations.” PLoS ONE 17 (4): e0266632. https://doi.org/10.1371/journal.pone.0266632.

Harvard

Tran, Q.-H. et al. (2022) ‘Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations’, PLoS ONE, 17(4), p. e0266632. doi:10.1371/journal.pone.0266632.

IEEE

Q.-H. Tran et al., “Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations,” PLoS ONE, vol. 17, no. 4, p. e0266632, 2022, doi: 10.1371/journal.pone.0266632.

BibTeX

@article{tran2022structure,
  title     = {{Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations}},
  author    = {Tran, Que-Huong and Nguyen, Quoc‐Thai and Vo, Nguyen-Quynh-Huong and Mai, Tan Thanh and Tran, Thi-Thuy-Nga and Tran, Thanh‐Dao and Le, Minh-Tri and Trinh, Dieu-Thuong Thi and Thai, Khac‐Minh},
  journal   = {PLoS ONE},
  year      = {2022},
  volume    = {17},
  number    = {4},
  pages     = {e0266632},
  doi       = {10.1371/journal.pone.0266632},
  url       = {https://doi.org/10.1371/journal.pone.0266632}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202255
20231313
20241414
20251717
202677

Its field-weighted citation impact is 3.73: it has been cited 3.73 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • interleukin-6
  • IL-6 receptor alpha
  • protein-protein interaction inhibitors
  • virtual screening
  • binding free energy
  • cytokine storm
  • COVID-19 pandemic
  • small molecule drug candidates

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Tran, Q.-H., Nguyen, Q., Vo, N.-Q.-H., Mai, T. T., Tran, T.-T.-N., Tran, T., Le, M.-T., Trinh, D.-T. T., & Thai, K. (2022). Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations. PLoS ONE, 17(4), e0266632. https://doi.org/10.1371/journal.pone.0266632

How many times has this paper been cited?

56 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PLoS ONE: sign in and open the PDF from this page.

Who wrote this paper?

Que-Huong Tran, Quoc‐Thai Nguyen, Nguyen-Quynh-Huong Vo, Tan Thanh Mai, Thi-Thuy-Nga Tran, Thanh‐Dao Tran, Minh-Tri Le, Dieu-Thuong Thi Trinh, Khac‐Minh Thai.

What is the DOI of this paper?

10.1371/journal.pone.0266632, permanently at https://doi.org/10.1371/journal.pone.0266632. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.